Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Omer Nisim"'
Publikováno v:
Chronic obstructive pulmonary diseases (Miami, Fla.). 5(4)
Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder which most commonly manifests as pulmonary emphysema. Accordingly, alpha-1 antitrypsin (AAT) augmentation therapy aims to reduce the progression of emphysema, as achieved by life-long weekly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::531ebec6c9d52724bce6ae8c25048bea
https://pubmed.ncbi.nlm.nih.gov/30723784
https://pubmed.ncbi.nlm.nih.gov/30723784
Autor:
Boris M. Baranovski, Omer Nisim, Ronen Schuster, Nofar Bahar, Eli C. Lewis, Galit Shahaf, Noa Kalay, Pablo Cal, Eran Schenker, Eyal Ozeri, David E. Ochayon, Mark Mizrahi, Pnina Strauss
Publikováno v:
The Journal of Pharmacology and Experimental Therapeutics
Lifelong weekly infusions of human α1-antitrypsin (hAAT) are currently administered as augmentation therapy for patients with genetic AAT deficiency (AATD). Several recent clinical trials attempt to extend hAAT therapy to conditions outside AATD, in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b04d8a1471437b9fe905b744d4cf9592
https://doi.org/10.1124/jpet.116.236067
https://doi.org/10.1124/jpet.116.236067